Multiple Sclerosis Pathology

Area of Science:

• Neuroimmunology
• Neuropathology

Background:

• Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease affecting the central nervous system (CNS).
• MS pathology involves focal lesions and diffuse neurodegeneration throughout the brain.
• Inflammation is recognized as a key driver of tissue injury across all disease stages.

Purpose of the Study:

• To review the spectrum of MS lesions.
• To describe the relationship between MS lesions and the inflammatory process.
• To explore the mechanisms of demyelination and neurodegeneration in MS.

Main Methods:

• Review of existing literature on MS pathology and inflammation.
• Analysis of pathological findings in MS lesions.
• Discussion of proposed mechanisms of inflammatory-induced CNS damage.

Main Results:

• Focal inflammatory infiltrates in meninges and perivascular spaces produce soluble factors.
• These factors induce demyelination and neurodegeneration, potentially via microglia activation.
• The precise nature of these demyelinating soluble factors remains undefined.
• Oxidative injury and mitochondrial damage contribute to demyelination and neurodegeneration, resulting in virtual hypoxia.

Conclusions:

• Inflammation is central to the pathogenesis of MS, driving tissue injury.
• Understanding the soluble factors involved is crucial for therapeutic development.
• Oxidative stress and mitochondrial dysfunction are key downstream events in MS pathogenesis.